Abstract
A 56 year old women was treated with megestrol acetate (Megace) 40 mg p.o. q.i.d. for her cerebellar metastasis of primary adenocarcinoma of the breast. She had previously undergone two surgical resections of her brain metastasis, and a course of radiotherapy. After failing to tolerate tamoxifen therapy, she received Megace, with marked improvement in her cerebellar tumor on CT scans. Despite good control of her brain tumor with Megace, she developed progressive neurological symptoms thought to be due to meningeal carcinomatosis, and died two years after initiating Megace therapy. We conclude that Megace could potentially be beneficial in some patients with brain metastases from adenocarcinoma of the breast.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tsukada Y, Fouad A, Pickren J, Lane W: Central nervous system metastasis from breast carcinoma: Autopsy study. Cancer 52: 2349–2354, 1983
Cairncross JG, Kim J-H, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529–541, 1980
Vick NA, Khandekar JD, Bigner DD: Chemotherapy of brain tumors. The ‘blood-brain barrier’ is not a factor. Arch Neurol 34: 523–526, 1977
Stewart DJ: A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neuro-Oncol 20: 121–139, 1994
Rosner D, Takuma N, Lane WW: Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58: 832–839, 1986
Hildebrand J, Brihaye J, Wagenknecht L, Michel J, Kenis Y: Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Europ J Cancer 11: 585–587, 1975
Lester SG, Morphis JG, Hornback NB, Williams SD, Einhorn LH: Brain metastases and testicular tumors: Need for aggressive therapy. J Clin Oncol 2: 1397–1403, 1984
Carey RW, Davis JM, Zervas NT: Tamoxifen-induced regression of cerebral metastases in breast carcinomas. Can Treat Rep 65: 793–795, 1981
Hansen SB, Galsgard H, von Eyben FE, Westergaard-Nielsen V, Wolf-Jensen J: Tamoxifen for brain metastases from breast cancer. Ann Neurol 20: 544, 1986
Pors H, von Eyben Fe, Sorensen OS, Larsen M: Longterm remission of multiple brain metastases with tamoxifen. J Neuro-Oncol 10: 173–177, 1991
van der Gaast A, Alexieva-Figusch J, Vecht C, Verweij J, Stoter G: Complete remission of a brain metastasis to third-line hormonal treatment with megestrol acetate. Am J Clin Oncol 13 (6): 507–509, 1990
Lundgren S: Progestins in breast cancer treatment. Acta Oncol 31: 709–722, 1992
Samaan NA, Buzdar AU, Aldinger KA, Schultz PN, Yang K-P, Romsdahl MM, Martin R: Estrogen receptor: A prognostic factor in breast cancer. Cancer 47: 554–560, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stewart, D.J., Dahrouge, S. Response of brain metastases from breast cancer to megestrol acetate: A case report. J Neuro-Oncol 24, 299–301 (1995). https://doi.org/10.1007/BF01052847
Issue Date:
DOI: https://doi.org/10.1007/BF01052847